Cite
Pettus J, Roussel R, Liz Zhou F, et al. Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study. Diabetes Ther. 2019;10(2):617-633doi: 10.1007/s13300-019-0568-8.
Pettus, J., Roussel, R., Liz Zhou, F., Bosnyak, Z., Westerbacka, J., Berria, R., Jimenez, J., Eliasson, B., Hramiak, I., Bailey, T., & Meneghini, L. (2019). Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 10(2), 617-633. https://doi.org/10.1007/s13300-019-0568-8
Pettus, Jeremy, et al. "Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 10,2 (2019): 617-633. doi: https://doi.org/10.1007/s13300-019-0568-8
Pettus J, Roussel R, Liz Zhou F, Bosnyak Z, Westerbacka J, Berria R, Jimenez J, Eliasson B, Hramiak I, Bailey T, Meneghini L. Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study. Diabetes Ther. 2019 Apr;10(2):617-633. doi: 10.1007/s13300-019-0568-8. Epub 2019 Feb 14. PMID: 30767173; PMCID: PMC6437256.
Copy
Download .nbib